Oregon Health and Science University, Portland.
Mary Bridge Children's Hospital, Tacoma, Washington.
JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):175-181. doi: 10.1001/jamaoto.2020.4548.
Persistent obstructive sleep apnea after adenotonsillectomy is common in children with Down syndrome or obesity. Drug-induced sleep endoscopy could help to identify anatomic differences in these patients that might affect surgical decision-making.
To assess drug-induced sleep endoscopy findings in surgically naive children with obstructive sleep apnea with obesity or Down syndrome and compare these findings with children without obesity or Down syndrome.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of data from a prospective cohort study of patients enrolled between May 1, 2015, and December 31, 2019, was conducted at an academic tertiary care children's hospital and included a consecutive sample of surgically naive children (age 2-18 years) who underwent drug-induced sleep endoscopy at the time of adenotonsillectomy for sleep-disordered breathing. Indications for sleep endoscopy included severe sleep apnea, age older than 7 years, obesity, African American race, and Down syndrome.
Drug-induced sleep endoscopy.
Sleep endoscopy findings were scored according to the Sleep Endoscopy Rating Scale. Ratings at 6 anatomic levels for children with obesity and those with Down syndrome were compared with controls without obesity or Down syndrome using several measures of effect size (Cohen d, Cramer V, and η2).
A total of 317 children (158 girls [50%]; 219 [69%] White, 20 [6%] Black, and 103 [34%] Hispanic; mean [95% CI] age, 9.6 [9.2-10.0] years) were included, of whom 115 (36%) were controls without obesity or Down syndrome, 179 (56%) had obesity without Down syndrome, and 23 (7%) had Down syndrome. The mean apnea-hypopnea index was 16 (95% CI, 13-19), and the mean minimum O2 saturation was 83% (95% CI, 81%-85%). Compared with controls without obesity or Down syndrome, children with Down syndrome demonstrated greater overall obstruction (mean sleep endoscopy rating scale total score of 5.6 vs 4.8; Cohen d, 0.46), and greater tonsillar (percentage of complete obstruction: 65% vs 54%), tongue base (percentage of complete obstruction: 26% vs 12%), and arytenoid obstruction (percentage of at least partial obstruction, 35% vs 6%). Children with obesity had greater tonsillar (percentage of complete obstruction, 74% vs 54%) and less base of tongue obstruction (percentage of complete obstruction, 2% vs 12%) compared with controls.
In this cohort study, surgically naive children with obesity with obstructive sleep apnea had predominantly tonsillar obstruction, whereas children with Down syndrome demonstrated greater obstruction of the tonsils, tongue base, and arytenoids compared with controls. Routine drug-induced sleep endoscopy should be considered in surgically naive children with Down syndrome to help inform the surgical plan.
腺样体扁桃体切除术(adenotonsillectomy)后持续性阻塞性睡眠呼吸暂停(obstructive sleep apnea)在唐氏综合征或肥胖儿童中很常见。药物诱导睡眠内镜检查(drug-induced sleep endoscopy)可以帮助识别这些患者的解剖差异,这些差异可能影响手术决策。
评估肥胖或唐氏综合征的阻塞性睡眠呼吸暂停(obstructive sleep apnea)初治儿童的药物诱导睡眠内镜检查结果,并与非肥胖或唐氏综合征儿童的检查结果进行比较。
设计、地点和参与者:这是一项在学术性三级儿童保健医院进行的前瞻性队列研究中开展的横断面数据分析,纳入了 2015 年 5 月 1 日至 2019 年 12 月 31 日期间行腺样体扁桃体切除术治疗睡眠呼吸障碍的初治儿童的连续样本,所有儿童均在该时段内行药物诱导睡眠内镜检查。睡眠内镜检查的指征包括严重睡眠呼吸暂停、年龄大于 7 岁、肥胖、非裔美国人、唐氏综合征。
药物诱导睡眠内镜检查。
根据睡眠内镜评分量表(Sleep Endoscopy Rating Scale)对睡眠内镜检查结果进行评分。使用几种效应量(Cohen d、Cramer V 和 η2)比较肥胖和唐氏综合征儿童的 6 个解剖部位评分与无肥胖或唐氏综合征的对照组。
共纳入 317 名儿童(158 名女孩[50%];219 名白人[69%],20 名黑人[6%],103 名西班牙裔[34%];平均[95%CI]年龄为 9.6[9.2-10.0]岁),其中 115 名(36%)为无肥胖或唐氏综合征的对照组,179 名(56%)为肥胖但无唐氏综合征,23 名(7%)为唐氏综合征。平均呼吸暂停低通气指数为 16(95%CI,13-19),平均最低氧饱和度为 83%(95%CI,81%-85%)。与无肥胖或唐氏综合征的对照组相比,唐氏综合征儿童的整体梗阻更为严重(平均睡眠内镜评分量表总分 5.6 比 4.8;Cohen d,0.46),且扁桃体(完全梗阻比例:65%比 54%)、舌基底(完全梗阻比例:26%比 12%)和杓状软骨(至少部分梗阻比例:35%比 6%)的梗阻更为严重。肥胖儿童的扁桃体(完全梗阻比例,74%比 54%)梗阻更严重,而舌基底(完全梗阻比例,2%比 12%)梗阻更轻。
在这项队列研究中,肥胖的阻塞性睡眠呼吸暂停初治儿童主要表现为扁桃体梗阻,而唐氏综合征儿童的扁桃体、舌基底和杓状软骨梗阻更为严重。对于唐氏综合征的初治儿童,应常规行药物诱导睡眠内镜检查,以帮助制定手术计划。